Veterans Health, Education and Benefit Fair to be Held at The Edinburg Conference Center at Renaissance

Translate to Spanish or other 102 languages!

 Mega Doctor News

- Advertisement -

 Edinburg, TX— Doctors Hospital at Renaissance Health System (DHR) is partnering with the Texas Veterans Commission, the Department of Veterans Affairs (VA), and the Texas Veterans Land Board (VLB) to host the “Veterans Health, Education and Benefits Fair” on Saturday, October 17, 2015 from 9:00 AM until 1:00 PM.  The fair will take place at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado (McColl Road and Alberta), Edinburg, TX, 78593. Veterans and their spouses are welcome to attend this event, free of charge.

“Doctors Hospital at Renaissance is pleased to co-sponsor this event along with state and federal agencies for the purpose of keeping Veterans in our area informed about services available to them for healthcare, housing, jobs and education,” states Israel Rocha, DHR Chief Executive Officer. “DHR is also pleased to announce that Francisco Fernandez, M.D., Dean of UTRGV School of Medicine, has agreed to join us for the welcoming ceremony at this event in support of Veterans healthcare services.” 

DHR is hosting the “Health, Education and Benefits Fair” for Veterans in an effort to bring together services from throughout Texas to one LRGV location, as well as to provide Veterans with the opportunity to check their current medical claim statuses

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -